Global Functional Dyspepsia Drug Market Insights and Forecast to 2027
1 Study Coverage
- 1.1 Functional Dyspepsia Drug Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Type
- 1.4.2 Prokinetic Drugs
- 1.4.3 Gastric Antisecretory Drugs
- 1.2.4 Others
- 1.3 Market by Application
- 1.3.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Application
- 1.3.2 Hospitals
- 1.3.3 Drugstores
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Functional Dyspepsia Drug Sales Estimates and Forecasts 2016-2027
- 2.2 Global Functional Dyspepsia Drug Revenue Estimates and Forecasts 2016-2027
- 2.3 Global Functional Dyspepsia Drug Revenue by Region: 2016 VS 2021 VS 2027
- 2.4 Global Top Functional Dyspepsia Drug Regions by Sales
- 2.4.1 Global Top Functional Dyspepsia Drug Regions by Sales (2016-2021)
- 2.4.2 Global Top Functional Dyspepsia Drug Regions by Sales (2022-2027)
- 2.5 Global Top Functional Dyspepsia Drug Regions by Revenue
- 2.5.1 Global Top Functional Dyspepsia Drug Regions by Revenue (2016-2021)
- 2.5.2 Global Top Functional Dyspepsia Drug Regions by Revenue (2022-2027)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Functional Dyspepsia Drug Sales by Manufacturers
- 3.1.1 Global Top Functional Dyspepsia Drug Manufacturers by Sales (2016-2021)
- 3.1.2 Global Top Functional Dyspepsia Drug Manufacturers Market Share by Sales (2016-2021)
- 3.1.3 Global Top 10 and Top 5 Companies by Functional Dyspepsia Drug Sales in 2020
- 3.2 Global Functional Dyspepsia Drug Revenue by Manufacturers
- 3.2.1 Global Top Functional Dyspepsia Drug Manufacturers by Revenue (2016-2021)
- 3.2.2 Global Top Functional Dyspepsia Drug Manufacturers Market Share by Revenue (2016-2021)
- 3.2.3 Global Top 10 and Top 5 Companies by Functional Dyspepsia Drug Revenue in 2020
- 3.3 Global Functional Dyspepsia Drug Sales Price by Manufacturers
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Functional Dyspepsia Drug Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Functional Dyspepsia Drug Sales by Type
- 4.1.1 Global Functional Dyspepsia Drug Historical Sales by Type (2016-2021)
- 4.1.2 Global Functional Dyspepsia Drug Forecasted Sales by Type (2022-2027)
- 4.1.3 Global Functional Dyspepsia Drug Sales Market Share by Type (2016-2027)
- 4.2 Global Functional Dyspepsia Drug Revenue by Type
- 4.2.1 Global Functional Dyspepsia Drug Historical Revenue by Type (2016-2021)
- 4.2.2 Global Functional Dyspepsia Drug Forecasted Revenue by Type (2022-2027)
- 4.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Type (2016-2027)
- 4.3 Global Functional Dyspepsia Drug Price by Type
- 4.3.1 Global Functional Dyspepsia Drug Price by Type (2016-2021)
- 4.3.2 Global Functional Dyspepsia Drug Price Forecast by Type (2022-2027)
5 Market Size by Application
- 5.1 Global Functional Dyspepsia Drug Sales by Application
- 5.1.1 Global Functional Dyspepsia Drug Historical Sales by Application (2016-2021)
- 5.1.2 Global Functional Dyspepsia Drug Forecasted Sales by Application (2022-2027)
- 5.1.3 Global Functional Dyspepsia Drug Sales Market Share by Application (2016-2027)
- 5.2 Global Functional Dyspepsia Drug Revenue by Application
- 5.2.1 Global Functional Dyspepsia Drug Historical Revenue by Application (2016-2021)
- 5.2.2 Global Functional Dyspepsia Drug Forecasted Revenue by Application (2022-2027)
- 5.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Application (2016-2027)
- 5.3 Global Functional Dyspepsia Drug Price by Application
- 5.3.1 Global Functional Dyspepsia Drug Price by Application (2016-2021)
- 5.3.2 Global Functional Dyspepsia Drug Price Forecast by Application (2022-2027)
6 North America
- 6.1 North America Functional Dyspepsia Drug Market Size by Type
- 6.1.1 North America Functional Dyspepsia Drug Sales by Type (2016-2027)
- 6.1.2 North America Functional Dyspepsia Drug Revenue by Type (2016-2027)
- 6.2 North America Functional Dyspepsia Drug Market Size by Application
- 6.2.1 North America Functional Dyspepsia Drug Sales by Application (2016-2027)
- 6.2.2 North America Functional Dyspepsia Drug Revenue by Application (2016-2027)
- 6.3 North America Functional Dyspepsia Drug Market Size by Country
- 6.3.1 North America Functional Dyspepsia Drug Sales by Country (2016-2027)
- 6.3.2 North America Functional Dyspepsia Drug Revenue by Country (2016-2027)
- 6.3.3 U.S.
- 6.3.4 Canada
7 Europe
- 7.1 Europe Functional Dyspepsia Drug Market Size by Type
- 7.1.1 Europe Functional Dyspepsia Drug Sales by Type (2017-2027)
- 7.1.2 Europe Functional Dyspepsia Drug Revenue by Type (2017-2027)
- 7.2 Europe Functional Dyspepsia Drug Market Size by Application
- 7.2.1 Europe Functional Dyspepsia Drug Sales by Application (2017-2027)
- 7.2.2 Europe Functional Dyspepsia Drug Revenue by Application (2017-2027)
- 7.3 Europe Functional Dyspepsia Drug Market Size by Country
- 7.3.1 Europe Functional Dyspepsia Drug Sales by Country (2017-2027)
- 7.3.2 Europe Functional Dyspepsia Drug Revenue by Country (2017-2027)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Functional Dyspepsia Drug Market Size by Type
- 8.1.1 Asia Pacific Functional Dyspepsia Drug Sales by Type (2018-2027)
- 8.1.2 Asia Pacific Functional Dyspepsia Drug Revenue by Type (2018-2027)
- 8.2 Asia Pacific Functional Dyspepsia Drug Market Size by Application
- 8.2.1 Asia Pacific Functional Dyspepsia Drug Sales by Application (2018-2027)
- 8.2.2 Asia Pacific Functional Dyspepsia Drug Revenue by Application (2018-2027)
- 8.3 Asia Pacific Functional Dyspepsia Drug Market Size by Region
- 8.3.1 Asia Pacific Functional Dyspepsia Drug Sales by Region (2018-2027)
- 8.3.2 Asia Pacific Functional Dyspepsia Drug Revenue by Region (2018-2027)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines
9 Latin America
- 9.1 Latin America Functional Dyspepsia Drug Market Size by Type
- 9.1.1 Latin America Functional Dyspepsia Drug Sales by Type (2019-2027)
- 9.1.2 Latin America Functional Dyspepsia Drug Revenue by Type (2019-2027)
- 9.2 Latin America Functional Dyspepsia Drug Market Size by Application
- 9.2.1 Latin America Functional Dyspepsia Drug Sales by Application (2019-2027)
- 9.2.2 Latin America Functional Dyspepsia Drug Revenue by Application (2019-2027)
- 9.3 Latin America Functional Dyspepsia Drug Market Size by Country
- 9.3.1 Latin America Functional Dyspepsia Drug Sales by Country (2019-2027)
- 9.3.2 Latin America Functional Dyspepsia Drug Revenue by Country (2019-2027)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
6 Middle East and Africa
- 6.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Type
- 6.1.1 Middle East and Africa Functional Dyspepsia Drug Sales by Type (2016-2027)
- 6.1.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Type (2016-2027)
- 6.2 Middle East and Africa Functional Dyspepsia Drug Market Size by Application
- 6.2.1 Middle East and Africa Functional Dyspepsia Drug Sales by Application (2016-2027)
- 6.2.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Application (2016-2027)
- 6.3 Middle East and Africa Functional Dyspepsia Drug Market Size by Country
- 6.3.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2016-2027)
- 6.3.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2016-2027)
- 6.3.3 Turkey
- 6.3.4 Saudi Arabia
- 6.3.5 UAE
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Overview
- 11.1.3 Bayer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.1.4 Bayer Functional Dyspepsia Drug Product Description
- 11.1.5 Bayer Related Developments
- 11.2 Sumitomo
- 11.2.1 Sumitomo Corporation Information
- 11.2.2 Sumitomo Overview
- 11.2.3 Sumitomo Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.2.4 Sumitomo Functional Dyspepsia Drug Product Description
- 11.2.5 Sumitomo Related Developments
- 11.3 Cadila Pharmaceuticals
- 11.3.1 Cadila Pharmaceuticals Corporation Information
- 11.3.2 Cadila Pharmaceuticals Overview
- 11.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Description
- 11.3.5 Cadila Pharmaceuticals Related Developments
- 11.4 Teva
- 11.4.1 Teva Corporation Information
- 11.4.2 Teva Overview
- 11.4.3 Teva Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.4.4 Teva Functional Dyspepsia Drug Product Description
- 11.4.5 Teva Related Developments
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Corporation Information
- 11.5.2 Johnson & Johnson Overview
- 11.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Description
- 11.5.5 Johnson & Johnson Related Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Corporation Information
- 11.6.2 Pfizer Overview
- 11.6.3 Pfizer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.6.4 Pfizer Functional Dyspepsia Drug Product Description
- 11.6.5 Pfizer Related Developments
- 11.7 Sanofi
- 11.7.1 Sanofi Corporation Information
- 11.7.2 Sanofi Overview
- 11.7.3 Sanofi Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.7.4 Sanofi Functional Dyspepsia Drug Product Description
- 11.7.5 Sanofi Related Developments
- 11.8 AstraZeneca
- 11.8.1 AstraZeneca Corporation Information
- 11.8.2 AstraZeneca Overview
- 11.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.8.4 AstraZeneca Functional Dyspepsia Drug Product Description
- 11.8.5 AstraZeneca Related Developments
- 11.9 Jiangsu Aosaikang Pharma
- 11.9.1 Jiangsu Aosaikang Pharma Corporation Information
- 11.9.2 Jiangsu Aosaikang Pharma Overview
- 11.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Description
- 11.9.5 Jiangsu Aosaikang Pharma Related Developments
- 11.10 Eisai
- 11.10.1 Eisai Corporation Information
- 11.10.2 Eisai Overview
- 11.10.3 Eisai Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.10.4 Eisai Functional Dyspepsia Drug Product Description
- 11.10.5 Eisai Related Developments
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Overview
- 11.1.3 Bayer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.1.4 Bayer Functional Dyspepsia Drug Product Description
- 11.1.5 Bayer Related Developments
- 11.12 Hanmi Pharm
- 11.12.1 Hanmi Pharm Corporation Information
- 11.12.2 Hanmi Pharm Overview
- 11.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.12.4 Hanmi Pharm Product Description
- 11.12.5 Hanmi Pharm Related Developments
12 Value Chain and Sales Channels Analysis
- 12.1 Functional Dyspepsia Drug Value Chain Analysis
- 12.2 Functional Dyspepsia Drug Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Functional Dyspepsia Drug Production Mode & Process
- 12.4 Functional Dyspepsia Drug Sales and Marketing
- 12.4.1 Functional Dyspepsia Drug Sales Channels
- 12.4.2 Functional Dyspepsia Drug Distributors
- 12.5 Functional Dyspepsia Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Functional Dyspepsia Drug Industry Trends
- 13.2 Functional Dyspepsia Drug Market Drivers
- 13.3 Functional Dyspepsia Drug Market Challenges
- 13.4 Functional Dyspepsia Drug Market Restraints
14 Key Findings in The Global Functional Dyspepsia Drug Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
Functional Dyspepsia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Functional Dyspepsia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
The classification of Functional Dyspepsia Drug includes Prokinetic Drugs, Gastric Antisecretory Drugs, etc. The proportion of Gastric Antisecretory Drugs in 2019 is about 47.86%.
Segment by Application
Hospitals
Drugstores
The application of Functional Dyspepsia Drug includes hospitals and drugstores. The proportion of hospitals in 2019 is about 63.85%.
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia